My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clarityn 10 mg Tablets



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/060/001

Main Information

Trade NameClarityn 10 mg Tablets
Active SubstancesLoratadine
Dosage FormTablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/060/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX13 loratadine

Status

License statusAuthorised
Licence Issued12/05/2023
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceFor pack sizes of up to 30 tablets: Product not subject to medical prescription. Supply as an over the counter item through pharmacies only. For pack sizes of more than 30 tablets: Product subject to medical prescription Supply through pharmacies only. Pack sizes not exceeding 30 tablets: Promotion to the public. Pack sizes exceeding 30 tablets: Promotion to healthcare professionals.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print